Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected].

Abstract

Batten disease, a degenerative neurological disorder with juvenile onset, is the most common form of the neuronal ceroid lipofuscinoses. Mutations in the CLN3 gene cause Batten disease. To facilitate studies of Batten disease pathogenesis and treatment, a murine model was created by targeted disruption of the Cln3 gene. Mice homozygous for the disrupted Cln3 allele had a neuronal storage disorder resembling that seen in Batten disease patients: there was widespread and progressive intracellular accumulation of autofluorescent material that by EM displayed a multilamellar rectilinear/fingerprint appearance. Inclusions contained subunit c of mitochondrial ATP synthase. Mutant animals also showed neuropathological abnormalities with loss of certain cortical interneurons and hypertrophy of many interneuron populations in the hippocampus. Finally, as is true in Batten disease patients, there was increased activity in the brain of the lysosomal protease Cln2/TPP-1. Our findings are evidence that the Cln3-deficient mouse provides a valuable model for studying Batten disease.

0204060'03'05'07'09'11'13'15'17
Citations per Year

214 Citations

Semantic Scholar estimates that this publication has 214 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Mitchison1999TargetedDO, title={Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected].}, author={Hannah M. Mitchison and Daniel J Bernard and Nicholas DE Greene and Jonathan D Cooper and Mohammed A. Junaid and Raju K. Pullarkat and Nicholas de Vos and Martijn H. Breuning and James W. Owens and William C. Mobley and R . Mark Gardiner and Brian D. Lake and Peter E. M. Taschner and Robert Nussbaum}, journal={Neurobiology of disease}, year={1999}, volume={6 5}, pages={321-34} }